RetractedArticlePharmaceutical research2015

RGD Peptide-Pegylated PLLA Nanoparticles Containing Epirubicin Hydrochloride Exhibit Receptor-Dependent Tumor Trafficking In Vitro and In Vivo.

Ping Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.